NGM Biopharmaceuticals Buy Hold or Sell Recommendation
| NGMDelisted Stock | USD 2.50 0.14 5.30% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding NGM Biopharmaceuticals is 'Not Rated'. The recommendation algorithm takes into account all of NGM Biopharmaceutica's available fundamental, technical, and predictive indicators you will find on this site.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. Note, we conduct extensive research on individual companies such as NGM and provide practical buy, sell, or hold advice based on investors' constraints. NGM Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
NGM |
Execute NGM Biopharmaceutica Buy or Sell Advice
The NGM recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NGM Biopharmaceuticals. Macroaxis does not own or have any residual interests in NGM Biopharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NGM Biopharmaceutica's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
NGM Biopharmaceutica Trading Alerts and Improvement Suggestions
| NGM Biopharmaceutica is not yet fully synchronised with the market data | |
| NGM Biopharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 4.42 M. Reported Net Loss for the year was (142.38 M) with loss before taxes, overhead, and interest of (125.73 M). | |
| NGM Biopharmaceuticals has about 297.81 M in cash with (132.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
NGM Biopharmaceutica Returns Distribution Density
The distribution of NGM Biopharmaceutica's historical returns is an attempt to chart the uncertainty of NGM Biopharmaceutica's future price movements. The chart of the probability distribution of NGM Biopharmaceutica daily returns describes the distribution of returns around its average expected value. We use NGM Biopharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NGM Biopharmaceutica returns is essential to provide solid investment advice for NGM Biopharmaceutica.
| Mean Return | -0.6 | Value At Risk | -8.8 | Potential Upside | 6.16 | Standard Deviation | 4.97 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NGM Biopharmaceutica historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Goeddel David V of 5840 shares of NGM Biopharmaceutica at 0.6211 subject to Rule 16b-3 [view details]
NGM Biopharmaceutica Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NGM . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About NGM Biopharmaceutica Buy or Sell Advice
When is the right time to buy or sell NGM Biopharmaceuticals? Buying financial instruments such as NGM Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having NGM Biopharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Market Neutral Funds Thematic Idea Now
Market Neutral Funds
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in NGM Stock
If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |